Enliven Therapeutics (ELVN.US) Shareholder Detail - Holdings History & Trades | Longbridge

FF

Fairmount Funds Management LLC

BuySellPriceUnit: Shares

Holdings History

Date
Latest	0.51%	+0	2.53%	1.86M	06/30/2026
Q2 2026	0.51%	+0	2.53%	1.86M	06/30/2026
Q1 2026	3.20%	-1.86M	3.05%	1.86M	03/31/2026
Q4 2025	0.02%	+0	6.24%	3.71M	12/31/2025
Q3 2025	<0.01%	+0	6.26%	3.71M	09/30/2025
Q2 2025	0.26%	+508.65K	6.27%	3.71M	06/30/2025
Q1 2025	0.01%	+0	6.53%	3.20M	03/31/2025
Q4 2024	0.23%	+0	6.54%	3.20M	12/31/2024
Q3 2024	0.01%	+0	6.78%	3.20M	09/30/2024
Q2 2024	0.06%	+0	6.79%	3.20M	06/30/2024
Q1 2024	1.68%	+1.07M	6.85%	3.20M	03/31/2024
Q4 2023	0.01%	+0	5.16%	2.13M	12/31/2023
Q3 2023	<0.01%	+6.74K	5.17%	2.13M	09/30/2023
Q2 2023	0.48%	+199.69K	5.16%	2.12M	06/30/2023
Q1 2023	--	+1.92M	4.68%	1.92M	03/31/2023